ECU Libraries Catalog

Implementing and evaluating genomic screening programs in health care systems : proceedings of a workshop / Siobhan Addie, Meredith Hackmann, Theresa Wizemann, and Sarah Beachy, rapporteurs ; Roundtable on Genomics and Precision Health, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine.

Author/creator Addie, Siobhan rapporteur.
Format Electronic and Book
Publication Info Washington, DC : The National Academies Press, 2018.
Description1 online resource (1 PDF file (xx, 130 pages)) : illustrations
Supplemental Content Direct link to resource
Other author/creatorHackmann, Meredith, rapporteur.
Other author/creatorWizemann, Theresa M., rapporteur.
Other author/creatorBeachy, Sarah H., rapporteur.
Other author/creatorNational Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on Genomics and Precision Health, issuing body.
Other author/creatorImplementing and Evaluating Genomic Screening Programs in Health Care Systems (Workshop) (2017 : Washington, D.C.)
Contents Introduction -- Evidence considerations for integrating genomics-based programs into health care systems -- Financial considerations for implementing genomics-based screening programs -- Exploring approaches to optimize data sharing among early implementers of genomics-based programs -- Understanding participant needs and preferences and improving diversity and equity -- Improving health through the integration of genomics-based programs: potential next steps.
Summary Genomic applications are being integrated into a broad range of clinical and research activities at health care systems across the United States. This trend can be attributed to a variety of factors, including the declining cost of genome sequencing and the potential for improving health outcomes and cutting the costs of care. The goals of these genomics-based programs may be to identify individuals with clinically actionable variants as a way of preventing disease, providing diagnoses for patients with rare diseases, and advancing research on genetic contributions to health and disease. Of particular interest are genomics- based screening programs, which will, in this publication, be clinical screening programs that examine genes or variants in unselected populations in order to identify individuals who are at an increased risk for a particular health concern (e.g., diseases, adverse drug outcomes) and who might benefit from clinical interventions. On November 1, 2017, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop to explore the challenges and opportunities associated with integrating genomics-based screening programs into health care systems. This workshop was developed as a way to explore the challenges and opportunities associated with integrating genomics-based programs in health care systems in the areas of evidence collection, sustainability, data sharing, infrastructure, and equity of access. This publication summarizes the presentations and discussions from the workshop.
General note"Proceedings of a workshop"--Cover.
Bibliography noteIncludes bibliographical references.
Funding informationThis project was supported by contracts between the National Academy of Sciences and 23andMe (unnumbered contract); Accenture (unnumbered contract); Air Force Medical Service (FA8052-17-P-0007); American Academy of Nursing (unnumbered contract); American College of Medical Genetics and Genomics (unnumbered contract); American Medical Association (unnumbered contract); American Society of Human Genetics (unnumbered contract); Association for Molecular Pathology (unnumbered contract); Biogen (unnumbered contract); Blue Cross and Blue Shield Association (unnumbered contract); College of American Pathologists (unnumbered contract); Color Genomics (unnumbered contract); Department of Veterans Affairs (Contract No. VA240-14-C-0037); Eisai Inc. (unnumbered contract); Eli Lilly and Company (unnumbered contract); Health Resources and Services Administration (HHSH250201500001I, Order No. HHSH250); Illumina, Inc. (unnumbered contract); Johnson & Johnson (unnumbered contract); Marc Grodman (unnumbered contract); Merck & Co., Inc. (Contract No. CMO-170216-001875); National Institutes of Health (Contract No. HHSN263201200074I; Task Order No. HHSN 26300093): National Cancer Institute; National Human Genome Research Institute; National Institute of Mental Health; National Institute of Nursing Research; National Institute on Aging; and Office of Disease Prevention; National Society of Genetic Counselors (unnumbered contract); and Northrop Grumman Health IT (unnumbered contract). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Source of descriptionOnline resource; title from PDF title page (viewed August 13, 2018).
Issued in other formPrint version: Addie, Siobhan. Implementing and evaluating genomic screening programs in health care systems. Washington, DC : National Academies Press, [2018] 9780309473415
Standard identifier# 10.17226/25048

Available Items

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available